Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
Both medications may be considered for individuals with obesity or who are overweight with at least one weight-related condition, such as high blood pressure, high cholesterol, or Type 2 diabetes
In September 2025, the U.S
The experiments were conducted according to the instructions
Full 16-week ladder 5-7 vials About 45.5 mg total used
Lead researcher Hamlet Gasoyan, DS, Ph.D., MPH, noted that patients treated for type 2 diabetes were more likely to restart treatment than those taking the drugs for obesity alone, likely because insurance coverage for these medications is currently broader for diabetes than for obesity
US$ 22.09
US$ 23.05
US$ 28.86
US$ 26.03
